Clinical trial
Scotoma Reduction in AMD Patients Treated With Ranibizumab
NCT00467935 · Retina Research Foundation, Other · Completed
Key facts
| NCT number | NCT00467935 |
|---|---|
| Title | Scotoma Reduction in AMD Patients Treated With Ranibizumab |
| Official title | A Phase I/II Study to Evaluate Scotoma Reduction in And Limited Visual Acuity in aGe Related Macular Degeneration Patients Treated With Intravitreal Lucentis |
| Acronym | SALVAGE |
| Lead sponsor | Retina Research Foundation, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | intravitreal injection Lucentis (ranibizumab) |
| Enrollment | 20 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 1, 2007 |
| Last update posted | Jul 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: